These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23377519)

  • 21. Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A.
    Schlessinger J; Kenkel J; Werschler P
    Aesthet Surg J; 2011 Jul; 31(5):529-39. PubMed ID: 21719866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroquinone-free multimodal topical regimen for facial hyperpigmentation.
    Foad MS; Winters E
    J Drugs Dermatol; 2013 Mar; 12(3):S42-4. PubMed ID: 23545933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
    Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
    Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical treatments for melasma and postinflammatory hyperpigmentation.
    Lynde CB; Kraft JN; Lynde CW
    Skin Therapy Lett; 2006 Nov; 11(9):1-6. PubMed ID: 17075653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation.
    Cook-Bolden FE; Hamilton SF
    Cutis; 2008 Apr; 81(4):365-71. PubMed ID: 18491487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia.
    Wang J; Fabi S; Robinson D; Bajaj S; Geronemus R; Bell M; Widgerow A
    J Drugs Dermatol; 2023 Apr; 22(4):333-338. PubMed ID: 37026875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream.
    Draelos ZD
    Dermatol Surg; 2005 Jul; 31(7 Pt 2):799-804. PubMed ID: 16029670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of the benefits of a topical treatment in the improvement of photodamaged hands with age spots, freckles, and/or discolorations.
    Gold MH; Gallagher C
    J Drugs Dermatol; 2013 Dec; 12(12):1468-72. PubMed ID: 24301250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study.
    Lowe N; Horwitz S; Tanghetti E; Draelos Z; Menter A
    J Cosmet Laser Ther; 2006 Sep; 8(3):121-7. PubMed ID: 16971360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hydroquinone formulation with increased stability and decreased potential for irritation.
    Smiles KA; Dong KK; Canning MT; Grimson R; Walfield AM; Yarosh DB
    J Cosmet Dermatol; 2007 Jun; 6(2):83-8. PubMed ID: 17524123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community-based trial of a triple-combination agent for the treatment of facial melasma.
    Grimes P; Kelly AP; Torok H; Willis I
    Cutis; 2006 Mar; 77(3):177-84. PubMed ID: 16610738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
    Mendoza CG; Singzon IA; Handog EB
    Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro and In Vivo Efficacy and Tolerability of a Non-Hydroquinone, Multi-Action Skin Tone Correcting Cream.
    Grimes PE; McDaniel DH; Wortzman M; Nelson D
    J Drugs Dermatol; 2019 Jul; 18(7):642-648. PubMed ID: 31329402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study.
    Woodhall KE; Goldman MP; Gold MH; Biron J
    J Drugs Dermatol; 2009 Sep; 8(9):862-7. PubMed ID: 19746679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies.
    Fleischer AB; Schwartzel EH; Colby SI; Altman DJ
    J Am Acad Dermatol; 2000 Mar; 42(3):459-67. PubMed ID: 10688717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroquinone-free Skin Brightener System for the Treatment of Moderate-to-severe Facial Hyperpigmentation.
    Herndon JH; Makino ET; Stephens TJ; Mehta RC
    J Clin Aesthet Dermatol; 2014 May; 7(5):27-31. PubMed ID: 24847406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
    Grimes PE
    Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
    Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
    J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma.
    Espinal-Perez LE; Moncada B; Castanedo-Cazares JP
    Int J Dermatol; 2004 Aug; 43(8):604-7. PubMed ID: 15304189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A method for maintaining the clinical results of 4% hydroquinone and 0.025% tretinoin with a cosmeceutical formulation.
    Draelos ZD; Raab S; Yatskayer M; Chen N; Krol Y; Oresajo C
    J Drugs Dermatol; 2015 Apr; 14(4):386-90. PubMed ID: 25844613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.